Journal Of Clinical Oncology SCIE

国际简称：J CLIN ONCOL 参考译名：临床肿瘤学杂志

主要研究方向：医学-肿瘤学非预警期刊审稿周期：约2月

《临床肿瘤学杂志》(Journal Of Clinical Oncology)是一本由American Society of Clinical Oncology出版的以医学-肿瘤学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

1区中科院分区
Q1 JCR分区
479 年发文量
42.1 IF影响因子
未开放 是否OA
494 H-index
1983 创刊年份
Biweekly 出版周期
English 出版语言

The Journal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer.

Print ISSN: 0732-183X

[ 查看全部 ]

投稿咨询加急咨询

Journal Of Clinical Oncology期刊信息

ISSN：0732-183X
出版语言：English
是否OA：未开放
E-ISSN：1527-7755
出版地区：UNITED STATES
是否预警：否
出版商：American Society of Clinical Oncology
出版周期：Biweekly
创刊时间：1983
开源占比：0.254
Gold OA文章占比：29.96%
OA被引用占比：0.1673...
出版国人文章占比：0.05
出版撤稿占比：0
研究类文章占比：96.87%

Journal Of Clinical Oncology CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

41.2

10.639

6.162

学科类别	分区	排名	百分位
大类：Medicine 小类：Oncology	Q1	9 / 404	97%
大类：Medicine 小类：Cancer Research	Q1	6 / 230	97%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Journal Of Clinical Oncology中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	ONCOLOGY 肿瘤学	1区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	ONCOLOGY 肿瘤学	1区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	ONCOLOGY 肿瘤学	1区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	ONCOLOGY 肿瘤学	1区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	ONCOLOGY 肿瘤学	1区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	ONCOLOGY 肿瘤学	1区

Journal Of Clinical Oncology JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q1	6 / 322	98.3%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q1	8 / 322	97.67%

Journal Of Clinical Oncology历年数据统计

影响因子

中科院分区

Journal Of Clinical Oncology中国学者发文选摘

1、Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
Author: Peng, Zhenwei; Fan, Wenzhe; Zhu, Bowen; Wang, Guoying; Sun, Junhui; Xiao, Chengjiang; Huang, Fuxi; Tang, Rong; Cheng, Yu; Huang, Zhen; Liang, Yuchuang; Fan, Huishuang; Qiao, Liangliang; Li, Fuliang; Zhuang, Wenquan; Peng, Baogang; Wang, Jiping; Li, Jiaping; Kuang, Ming

Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 1, pp. 117-+. DOI: 10.1200/JCO.22.00392
2、Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial
Author: Zhang, Haiyan; Fan, Zhiping; Huang, Fen; Han, Lijie; Xu, Yajing; Xu, Na; Deng, Lan; Wang, Shunqing; Lin, Dongjun; Luo, Xiaodan; Zhang, Qing; Liu, Xiaodan; Li, Xudong; Liang, Xinquan; Xie, Shuangfeng; Qu, Hong; Yu, Sijian; Zhou, Hongsheng; Shi, Pengcheng; Xuan, Li; Lin, Ren; Liu, Hui; Jin, Hua; Sun, Jing; Liu, Qifa

Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 2, pp. 343-+. DOI: 10.1200/JCO.22.00767
3、Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial
Author: Drilon, Alexander; Subbiah, Vivek; Gautschi, Oliver; Tomasini, Pascale; de Braud, Filippo; Solomon, Benjamin J.; Tan, Daniel Shao-Weng; Alonso, Guzman; Wolf, Juergen; Park, Keunchil; Goto, Koichi; Soldatenkova, Victoria; Szymczak, Sylwia; Barker, Scott S.; Puri, Tarun; Bence Lin, Aimee; Loong, Herbert; Besse, Benjamin

Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 2, pp. 385-+. DOI: 10.1200/JCO.22.00393
4、Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)
Author: Wang, Zhijie; Wu, Lin; Li, Baolan; Cheng, Ying; Li, Xiaoling; Wang, Xicheng; Han, Liang; Wu, Xiaohong; Fan, Yun; Yu, Yan; Lv, Dongqing; Shi, Jianhua; Huang, Jianjin; Zhou, Shaozhang; Han, Baohui; Sun, Guogui; Guo, Qisen; Ji, Youxin; Zhu, Xiaoli; Hu, Sheng; Zhang, Wei; Wang, Qiming; Jia, Yuming; Wang, Ziping; Song, Yong; Wu, Jingxun; Shi, Meiqi; Li, Xingya; Han, Zhigang; Liu, Yunpeng; Yu, Zhuang; Liu, An-Wen; Wang, Xiuwen; Zhou, Caicun; Zhong, Diansheng; Miao, Liyun; Zhang, Zhihong; Zhao, Hui; Yang, Jun; Wang, Dong; Wang, Yingyi; Li, Qiang; Zhang, Xiaodong; Ji, Mei; Yang, Zhenzhou; Cui, Jiuwei; Gao, Beili; Wang, Buhai; Liu, Hu; Nie, Lei; He, Mei; Jin, Shi; Gu, Wei; Shu, Yongqian; Zhou, Tong; Feng, Jian; Yang, Xinmei; Huang, Cheng; Zhu, Bo; Yao, Yu; Tang, Xiongwen; Yu, Jianjun; Maher, Ellen; Feng, Hui; Yao, Sheng; Keegan, Patricia; Wang, Jie

Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 3, pp. 651-+. DOI: 10.1200/JCO.22.00727
5、BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers
Author: Sun, Jie; Chu, Futao; Pan, Jiani; Zhang, Yaxin; Yao, Lu; Chen, Jiuan; Hu, Li; Zhang, Juan; Xu, Ye; Wang, Xiaojia; Cao, Wenming; Xie, Yuntao

Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 5, pp. 991-+. DOI: 10.1200/JCO.22.00833
6、Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial
Author: Hillmen, Peter; Eichhorst, Barbara; Brown, Jennifer R.; Lamanna, Nicole; O'Brien, Susan M.; Tam, Constantine S.; Qiu, Lugui; Kazmierczak, Maciej; Zhou, Keshu; Simkovic, Martin; Mayer, Jiri; Gillespie-Twardy, Amanda; Shadman, Mazyar; Ferrajoli, Alessandra; Ganly, Peter S.; Weinkove, Robert; Grosicki, Sebastian; Mital, Andrzej; Robak, Tadeusz; Osterborg, Anders; Yimer, Habte A.; Salmi, Tommi; Ji, Meng; Yecies, Jessica; Idoine, Adam; Wu, Kenneth; Huang, Jane; Jurczak, Wojciech

Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 5, pp. 1035-+. DOI: 10.1200/JCO.22.00510
7、Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial
Author: Qin, Shukui; Chen, Zhendong; Fang, Weijia; Ren, Zhenggang; Xu, Ruocai; Ryoo, Baek-Yeol; Meng, Zhiqiang; Bai, Yuxian; Chen, Xiaoming; Liu, Xiufeng; Xiao, Juxiang; Ho, Gwo Fuang; Mao, Yimin; Wang, Xin; Ying, Jieer; Li, Jianfeng; Zhong, Wenyan; Zhou, Yu; Siegel, Abby B.; Hao, Chunyi

Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 7, pp. 1434-+. DOI: 10.1200/JCO.22.00620
8、Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial.
Author: Jiang J¹, Li Y¹, Shen Q^1,², Rong X¹, Huang X¹, Li H¹, Zhou L³, Mai HQ⁴, Zheng D⁵, Chen MY⁴, Xu Y¹, Li J⁴, Hui X⁶, Simone CB 2nd⁷, Gaertner J⁸, Argyriou AA⁹, Chow E¹⁰, Chen P³, Tang Y¹.

Journal: J Clin Oncol. 2019 Jan 10;37(2):135-143. doi: 10.1200/JCO.18.00896. Epub 2018 Nov 20.